Stockscreener 앱 받기
44.06
0.02%
-0.010
시간 외 거래:
44.06
Livanova Plc 주식(LIVN)의 최신 뉴스
Vagus Nerve Stimulators Market Is Booming Worldwide | LivaNova - openPR.com
New Trial Reveals Sustained Benefits for Investigational Sleep Apnea Neurostimulator - Sleep Review
Jefferies lifts Livanova stock price target to $79 from $74 - Investing.com Australia
LivaNova (LIVN) Receives Price Target Boost from Baird | LIVN Stock News - GuruFocus
LivaNova Q1 2025 revenue increases 7.4% to USD 316.9M - Medical Buyer
Barclays Adjusts LivaNova (LIVN) Price Target Amid Strong Performance | LIVN Stock News - GuruFocus
LivaNova PLC (LIVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances - Yahoo
LivaNova PLC Reports Strong Q1 2025 Results - TipRanks
Jefferies lifts Livanova stock price target to $79 from $74 By Investing.com - Investing.com South Africa
LivaNova: Q1 Earnings Snapshot - MySA
LivaNova PLC earnings beat by $0.12, revenue topped estimates - Investing.com Nigeria
LivaNova PLC SEC 10-Q Report - TradingView
Are LivaNova PLC's (NASDAQ:LIVN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - Yahoo Finance
LivaNova Q1 2025 Earnings Call Transcript - MarketBeat
Will LivaNova's Growth And Innovation Drive Sustained Gains In 2025? - Nasdaq
LivaNova submits nerve stim for sleep apnea to FDA, raises 2025 guidance - MassDevice
LivaNova Q1 Adjusted Earnings, Net Revenue Rise; 2025 Outlook Revised - marketscreener.com
LivaNova PLC Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
LIVN Surpasses Q1 Revenue Expectations with Robust Growth | LIVN Stock News - GuruFocus
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance - BioSpace
LivaNova PLC Q1 2025 Earnings: Revenue Hits $316.9M, Adjusted EPS Soars to $0.88, Both Surpass Estimates - GuruFocus
LIVN Reports Promising 12-Month Results from OSPREY Sleep Apnea Trial | LIVN Stock News - GuruFocus
LivaNova plc (LIVN) Tops Q1 EPS by 12c ; Offers Guidance - StreetInsider
Earnings Flash (LIVN) LIVANOVA PLC Reports Q1 Revenue $316.9M, vs. FactSet Est of $302.4M - marketscreener.com
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy | LIVN Stock News - GuruFocus
LivaNova Announces 12-Month Data From Osprey Clinical Study For Moderate To Severe Obstructive Sleep Apnea, Demonstrating Strong Response And Durability Of Therapy - marketscreener.com
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy - Business Wire
Should Weakness in LivaNova PLC's (NASDAQ:LIVN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st
How the (LIVN) price action is used to our Advantage - news.stocktradersdaily.com
Medical Implants Market Projected To Witness Substantial - openPR.com
Is LivaNova PLC (LIVN) the Best Undervalued UK Stock to Buy Right Now? - Insider Monkey
Vagus Nerve Stimulators Market Set to Witness Significant - openPR.com
Mizuho Adjusts Price Target for LivaNova (LIVN) Ahead of Q1 Prev - GuruFocus
What Is LivaNova PLC's (NASDAQ:LIVN) Share Price Doing? - Yahoo Finance
LivaNova PLC (LIVN): Among the Best UK Stocks to Buy According to Billionaires - Insider Monkey
Cardiovascular Devices Market Demand, Growth and Future Scope - openPR.com
Vagus Nerve Stimulators Market Deep Research Report with - openPR.com
With LivaNova PLC (NASDAQ:LIVN) It Looks Like You'll Get What You Pay For - simplywall.st
Aortic Stenosis Market to Witness Massive Growth by 2032 | - openPR.com
10 Best UK Stocks to Buy According to Billionaires - Insider Monkey
LivaNova PLC: Excellent Revenue Earner, Some Short-Term Litigation Concerns (LIVN) - Seeking Alpha
Enovis appoints Damien McDonald as CEO - MedTech Dive
LivaNova stock plunges to 52-week low, touches $36.18 By Investing.com - Investing.com Canada
LivaNova stock plunges to 52-week low, touches $36.18 - Investing.com Australia
0.11%
0.79%
자본화:
|
볼륨(24시간):